Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-955176 in treatment-naive HIV-1
NCT02415595Phase 2Terminated
- Sponsor
- ViiV Healthcare
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of BMS-955176 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started May 2015; status: terminated.
02
Drugs
BMS-955176
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02415595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415595.